Macrophages as a Cell-Based Therapy for Liver Disease

Philip J Starkey Lewis, Francesca Moroni, Stuart J Forbes* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.

Original languageEnglish
Pages (from-to)442-451
Number of pages9
JournalSeminars in Liver Disease
Volume39
Issue number4
Early online date26 Jun 2019
DOIs
Publication statusPublished - 2019

Fingerprint

Cell- and Tissue-Based Therapy
Liver Diseases
Macrophages
Acute Liver Failure
Tissue Distribution
Phagocytes
Innate Immunity
Liver Transplantation
Immune System
Chronic Disease
Pathology
Phenotype
Liver
Therapeutics

Keywords

  • macrophages
  • cirrhosis
  • acetaminophen
  • liver immunology
  • cell therapy
  • FUNGAL-INFECTION
  • INFLAMMATORY RESPONSE SYNDROME
  • RETICULOENDOTHELIAL SYSTEM
  • BONE-MARROW
  • FUNCTIONAL-CHARACTERIZATION
  • MESENCHYMAL STEM-CELLS
  • HEPATOCYTE-LIKE CELLS
  • KUPFFER CELLS
  • STEM/PROGENITOR CELLS
  • INFILTRATING MACROPHAGES

ASJC Scopus subject areas

  • Hepatology

Cite this

Macrophages as a Cell-Based Therapy for Liver Disease. / Starkey Lewis, Philip J; Moroni, Francesca; Forbes, Stuart J (Corresponding Author).

In: Seminars in Liver Disease, Vol. 39, No. 4, 2019, p. 442-451.

Research output: Contribution to journalArticle

Starkey Lewis, Philip J ; Moroni, Francesca ; Forbes, Stuart J. / Macrophages as a Cell-Based Therapy for Liver Disease. In: Seminars in Liver Disease. 2019 ; Vol. 39, No. 4. pp. 442-451.
@article{b7f6d286f0aa4f67aefef78bb6d18865,
title = "Macrophages as a Cell-Based Therapy for Liver Disease",
abstract = "Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.",
keywords = "macrophages, cirrhosis, acetaminophen, liver immunology, cell therapy, FUNGAL-INFECTION, INFLAMMATORY RESPONSE SYNDROME, RETICULOENDOTHELIAL SYSTEM, BONE-MARROW, FUNCTIONAL-CHARACTERIZATION, MESENCHYMAL STEM-CELLS, HEPATOCYTE-LIKE CELLS, KUPFFER CELLS, STEM/PROGENITOR CELLS, INFILTRATING MACROPHAGES",
author = "{Starkey Lewis}, {Philip J} and Francesca Moroni and Forbes, {Stuart J}",
note = "Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.",
year = "2019",
doi = "10.1055/s-0039-1688502",
language = "English",
volume = "39",
pages = "442--451",
journal = "Seminars in Liver Disease",
number = "4",

}

TY - JOUR

T1 - Macrophages as a Cell-Based Therapy for Liver Disease

AU - Starkey Lewis, Philip J

AU - Moroni, Francesca

AU - Forbes, Stuart J

N1 - Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

PY - 2019

Y1 - 2019

N2 - Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.

AB - Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.

KW - macrophages

KW - cirrhosis

KW - acetaminophen

KW - liver immunology

KW - cell therapy

KW - FUNGAL-INFECTION

KW - INFLAMMATORY RESPONSE SYNDROME

KW - RETICULOENDOTHELIAL SYSTEM

KW - BONE-MARROW

KW - FUNCTIONAL-CHARACTERIZATION

KW - MESENCHYMAL STEM-CELLS

KW - HEPATOCYTE-LIKE CELLS

KW - KUPFFER CELLS

KW - STEM/PROGENITOR CELLS

KW - INFILTRATING MACROPHAGES

UR - http://www.scopus.com/inward/record.url?scp=85073579045&partnerID=8YFLogxK

U2 - 10.1055/s-0039-1688502

DO - 10.1055/s-0039-1688502

M3 - Article

C2 - 31242527

VL - 39

SP - 442

EP - 451

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

IS - 4

ER -